Concepedia

Homayoon Khanlou

HK

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

2008

Affiliations

AIDS Healthcare Foundation(Current)

Orlando Immunology Center

University of California, Los Angeles

Institute for Interdisciplinary Medicine

Chiang Mai University

Homayoon Khanlou is an author at AIDS Healthcare Foundation specializing in antiretroviral therapy, hiv antiretroviral therapy, and antiviral therapy.

Publications per year

2008–2014

8

Publications

8

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

Roberto Ortiz, Edwin DeJesus, Homayoon Khanlou et al. · AIDS · 2008 · 383 citations

, , +17

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr et al. · Nature Medicine · 2009 · 263 citations · Full text

, , +13

Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in <scp>HIV</scp>‐1‐infected treatment‐naïve patients in the <scp>ARTEMIS</scp> trial

Chloe Orkin, E DeJesus, Homayoon Khanlou et al. · HIV Medicine · 2012 · 158 citations · Full text

, , +17

Immunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled Trial

Otto O. Yang, Theodoros Kelesidis, Robert Cordova et al. · AIDS Research and Human Retroviruses · 2014 · 89 citations

, , +17

Barriers and Unmet Need for Supportive Services for HIV Patients in Care in Los Angeles County, California

Amy Rock Wohl, Juli-Ann Carlos, Judith S. Tejero et al. · AIDS Patient Care and STDs · 2011 · 50 citations

, , +16

1–5 of 8